• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Eli Lilly (NY:LLY)

    978.34 +29.89 (+3.15%)
    Streaming Delayed Price Updated: 10:18 AM EDT, May 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Eli Lilly

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly
    Via Investor Brand Network
    The Next Generation of the GLP-1 Revolution Is Already Underway
    Via Investor Brand Network
    News headline image
    Phase III Trial Enrollment Reached (75%) for Promising Anti-Inflammatory and Anti-Fibrotic Cardiac Therapies by Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)
    Via Get News
    Topics Intellectual Property
    News headline image
    The Next Generation of the GLP-1 Revolution Is Already Underway
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Correction: Positive Results on MAVERIC Phase 2 and Published ARCHER Study Presented by the Company CEO in Live Interview with Barchart: Cardiol Therapeutics Inc. (NASDAQ: CRDL)
    Via Get News
    Topics Intellectual Property
    News headline image
    Expert Matchmaker in Indianapolis Report by CX Research Institute
    Via AB Newswire
    Topics Economy
    News headline image
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
    From stem cell therapies for frailty to α-Klotho protein programs and GLP-1 drug classes now labeled "longevity therapeutics," the science and the capital have finally met 
    From Equity Insider
    Via GlobeNewswire
    News headline image
    $30 Billion Per Year US Heart Failure Market Presents Huge Opportunity for Promising Drugs Advancing with Positive Trial Results for Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)
    Via Get News
    Topics Intellectual Property
    News headline image
    ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside
    Via AB Newswire
    News headline image
    Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
    The number of oral weight-loss / diabetes drug treatments is expanding, increasing demand for the reduction of side effects 
    Via TheNewswire.com
    News headline image
    Renovations and Equipment Upgrades Fell 18% in February 2026; Other Capital Projects Remain Stable
    JACKSONVILLE BEACH, Fla., March 5, 2026 (SEND2PRESS NEWSWIRE) -- Industrial SalesLeads released its February 2026 Planned Capital Project Spending Report for the Industrial Manufacturing sector. The... 
    Via Send2Press
    TinyGemsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Dr. Freda Lewis-Hall to Board and Scientific Advisory Committee Chair
    Via Investor Brand Network
    News headline image
    Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
    In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel serotonergic agonist (“NSA”) portfolio This news release... 
    Via FinancialNewsMedia
    News headline image
    ELI LILLY AND COMPANY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLY
    From Scott+Scott Attorneys at Law LLP
    Via Business Wire
    Veteran Biopharma Engineer Ge Yang Attracts Investor Interest with Vision to Redefine Global Pharma Manufacturing
    Via AB Newswire
    News headline image
    VenHub Appoints Former Amazon Executive, Ian Rasmussen, to Spearhead Nationwide Smart Store Expansion with Focus on Strategic Partnerships and Enterprise Integrations
    VenHub Global, Inc. (NASDAQ:VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today announced the appointment of Ian Rasmussen as 
    Via PressReach
    News headline image
    Carvina Capital: Strong Demand Lifts Aktis IPO
    Via AB Newswire
    News headline image
    ELI LILLY AND COMPANY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLY
    From Scott+Scott Attorneys at Law LLP
    Via Business Wire
    News headline image
    Obesity Medicine Association Releases Position Statement: A New Era for Medicare & Medicaid Obesity Medication Coverage
    Centennial, Colorado--(Newsfile Corp. - December 24, 2025) - The Obesity Medicine Association (OMA) released its Position Statement on Medicare and... 
    Via Newsfile
    News headline image
    New Obesity Medicine Association Initiative Aims to Scale High-Impact Obesity Healthcare Improvements Nationwide
    Centennial, Colorado--(Newsfile Corp. - December 18, 2025) - The Obesity Medicine Association (OMA) is pleased to announce a new multi-phase... 
    Via Newsfile
    News headline image
    November 2025 Marks Seven Straight Months of Growth with 154 New Industrial Capital Projects
    JACKSONVILLE BEACH, Fla., Dec. 4, 2025 (SEND2PRESS NEWSWIRE) -- Industrial SalesLeads today announced the findings of its November 2025 report on planned capital project spending within the North... 
    Via Send2Press
    Topics Artificial Intelligence
    Biotech Valuations Rise as New Clinical Platforms Show Progress
    Via Investor Brand Network
    News headline image
    Biotech Valuations Rise as New Clinical Platforms Show Progress
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Correction and Clarification: Trifecta and Edward Fruitman, M.D., Do Not Maintain Any Contractual Relationship or Product Preference With Eli Lilly or LillyDirect®
    November 20, 2025 -- The organization reiterates it has no partnership with Lilly and does not endorse or favor Eli Lilly products, including Zepbound®, in its weight-loss and medical services. 
    Via 24-7 Press Release
    Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
    Via Investor Brand Network
    News headline image
    Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
    EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NYSE:LLY),(NYSE:JNJ) EQNX::TICKER_END 
    Via FinancialNewsMedia
    4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA)
    Via AB Newswire
    Big Pharma Just Put Peptides Back on the Map – Which Players Are Still Under the Radar?
    Via AB Newswire
    News headline image
    Novo Nordisk’s “Employee Diet” Trims Workforce By 9,000
    Via AB Newswire
    Topics Economy Workforce
    News headline image
    2024 R&D Spending and Intensity Benchmarks
    Via PRLog
    Topics Supply Chain
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.